Developing novel oral peptide therapeutics and exploring the wild world of immunobiology, Vice President and Head of Biology at Nimble Therapeutics
Boston, MA
Joined September 2015
- Tweets155
- Following484
- Followers112
- Likes448
Excited to join @nimbletherapeutics as VP & Head of Biology! We’re developing novel oral peptide therapeutics using our groundbreaking platform #immunology #oralpeptide
Munir Mosaheb retweeted
Excited to share that Laronde & @sendabioscience have merged to form @SailBiomeds , a new company pioneering the design & deployment of fully programmable medicines to transform patient care! Follow us @SailBiomeds #FlagshipFounded #eRNA @FlagshipPioneer
Munir Mosaheb retweeted
Flagship launches Sail Biomedicines (@SailBiomeds), which combines #FlagshipFounded @endlessRNA and @sendabioscience, along with AI capabilities from Flagship Labs to form a new company pioneering the design and deployment of fully programmable medicines. More here: flagshippioneering.com/press…
#ipnc2023 it was a pleasure to be part of this panel and I really enjoyed meeting old friends and making new ones, thank you for inviting me to be a speaker on your panel
We are extremely lucky to welcome Boston Biotech professionals this morning to discuss their work.
"It is extremely important to continue to foster this relationship between academia and industry." - Caroline Genco, PhD (@TuftsUniversity)
#IPNC2023
Munir Mosaheb retweeted
A novel subset of tissue-resident memory T cells may contribute to lung immunity during #pneumococcal #pneumonia mucosalimmunology.org/articl…
Munir Mosaheb retweeted
My new book is out today- ‘Show me the Science’- adapted from ‘Never mind the B*ll*cks Here’s the Science’ for teens by Shelia Armstrong who did a great job . You can order here:
books.ie/show-me-the-sc…
amazon.co.uk/Show-Me-Scienc…
#ShowMetheScience #GillBooksAW23 – at Boston, MA
Munir Mosaheb retweeted
We are thrilled to be recognized on @fastcompany’s list of World Changing Ideas for our pioneering work to use nature’s codes to fully unlock #programmablemedicines & bring life-improving treatments to patients.
Read more: sendabiosciences.com/press/s…
#FCWorldChangingIdeas #SendRNA
Thrilled to be presenting Senda Biosciences exciting science at #DDSS2023
Senda’s Head of Translational Biology, Munir Mosaheb, will present at the 12th Drug Discovery Strategic Summit 2023 in #Boston next week. His talk on harnessing nature to unlock #programmablemedicines is May 3 at 4:50pm ET.
#SendRNA #SendAtlas #DDSS2023
Munir Mosaheb retweeted
On @Big4Bio’s #CompanytoWatch podcast, we talk about how Senda is applying modeling and AI to our unique #SendAtlas to build a pipeline of new medicines. We’ll first focus on #immunotherapy, given the area’s unmet medical need.
🎙️ Listen here: bit.ly/3og4p6D
Excited to have an excellent immunologist Luke Oneill @laoneill111 join us @sendabioscience , looking forward to do some great science together sendabiosciences.com/press/s…
Munir Mosaheb retweeted
Today we welcome Dr. Luke O’Neill, a world-renowned immunologist, as our CSO. His valuable insights will be essential as we position our platform to focus initially on #programmablemedicines in #immunology.
sendabiosciences.com/press/s…
I am thrilled to share that we have raised 123 million dollars for our Series C, paving the way for @sendabioscience to continue to build our platform and advance programmable medicine to patients
We’re thrilled to announce the close of our Series C #financing to advance our first-of-its-kind platform accessing nature’s codes to develop #programmablemedicines that are targeted, potent, and tunable for a broad range of diseases.
@FlagshipPioneer
sendabiosciences.com/press/s…
Munir Mosaheb retweeted
Celebrating a company milestone today, cutting the ribbon to officially open another 2,200 sq. ft. of brand new BSL2 lab space, complete with autoclave, glasswasher, and consumables storage. Pretty spiffy!
#SendaScience #CreatingProgrammableMedicines
Munir Mosaheb retweeted
Thank you @FierceBiotech for including us in the 2021 Fierce 15 list. We’re excited Fierce recognizes the promise of Intersystems Biology, our X-VIA™ platform and our work developing next-generation nucleic acid, genetic, and protein-based therapies. bit.ly/3AP8L6q
Munir Mosaheb retweeted
We’re excited to announce that Senda’s CEO, Guillaume Pfefer, Ph.D., has been named to the 2021 #PharmaVoice100 Congratulations to Guillaume and all of this year's honorees. bit.ly/3ilbP3o
I am looking for two RA/Sr.RA to join my Translational Biology group at Senda Biosciences to join my immunology group to do some exciting science and develop new therapeutics for patients, apply to this position Check out this job from Senda Biosciences linkedin.com/jobs/view/26599…
I am looking for a talented in vivo biologist to lead the in vivo pharmacology team in my group at Senda Biosciences. If interested to join my immunology group to do some exciting science and develop new therapeutics for patients, apply to this position linkedin.com/jobs/view/26599…
Munir Mosaheb retweeted
mRNA Vaccines May Pack More Persistent Punch Against COVID-19 Than Thought – NIH Director's Blog directorsblog.nih.gov/2021/0…